Gemcitabine and vinorelbine combinations in the treatment of non-small cell lung cancerHERBST, R. S; LILENBAUM, R.Seminars in oncology. 1999, Vol 26, Num 5, pp 67-70, issn 0093-7754, SUP16Conference Paper

Development and testing of SREX flowsheets for treatment of Idaho chemical processing plant sodium-bearing waste using centrifugal contactorsLAW, J. D; WOOD, D. J; HERBST, R. S et al.Separation science and technology. 1997, Vol 32, Num 1-4, pp 223-240, issn 0149-6395Conference Paper

EGFR biomarkers predict benefit from vandetanib in combination with docetaxel in a randomized phase III study of second-line treatment of patients with advanced non-small cell lung cancerHEYMACH, J. V; LOCKWOOD, S. J; HERBST, R. S et al.Annals of oncology. 2014, Vol 25, Num 10, pp 1941-1948, issn 0923-7534, 8 p.Article

Acute in vivo resistance in high-dose therapyTEICHER, B. A; ARA, G; KEYES, S. R et al.Clinical cancer research. 1998, Vol 4, Num 2, pp 483-491, issn 1078-0432Article

Phase I trial of axitinib combined with platinum doublets in patients with advanced non-small cell lung cancer and other solid tumoursKOZLOFF, M. F; MARTIN, L. P; ROSBROOK, B et al.British journal of cancer. 2012, Vol 107, Num 8, pp 1277-1285, issn 0007-0920, 9 p.Article

Evaluation of pharmacodynamic biomarkers in a Phase Ia trial of dulanermin (rhApo2UTRAIL) in patients with advanced tumoursPAN, Y; XU, R; PEACH, M et al.British journal of cancer. 2011, Vol 105, Num 12, pp 1830-1838, issn 0007-0920, 9 p.Article

Emerging therapies in non-small-cell lung cancerKHURI, F. R; HERBST, R. S; FOSSELLA, F. V et al.Annals of oncology. 2001, Vol 12, Num 6, pp 739-744, issn 0923-7534Article

Development and demonstration of solvent extraction processes for the separation of radionuclides from acidic radioactive wasteLAW, J. D; BREWER, K. N; HERBST, R. S et al.Waste management (Elmsford). 1999, Vol 19, Num 1, pp 27-37, issn 0956-053XArticle

Tyrosine hydroxylase-immunoreactive neurons of the hypothalamus: a light and electron microscopic studyVAN DEN POL, A. N; HERBST, R. S; POWELL, J. F et al.Neuroscience. 1984, Vol 13, Num 4, pp 1117-1156, issn 0306-4522Article

A retrospective analysis of the outcome of patients who have received two prior chemotherapy regimens including platinum and docetaxel for recurrent non-small-cell lung cancerMASSARELLI, E; ANDRE, F; LIU, D. D et al.Lung cancer. 2003, Vol 39, Num 1, pp 55-61, issn 0169-5002, 7 p.Article

Paclitaxel/carboplatin administration along with antiangiogenic therapy in non-small-cell lung and breast carcinoma modelsHERBST, R. S; TAKEUCHI, H; TEICHER, B. A et al.Cancer chemotherapy and pharmacology. 1998, Vol 41, Num 6, pp 497-504, issn 0344-5704Article

The state of cellular differentiation determine the activity of the adenovirus E1A enhancer element: evidence for negative regulation of enhancer functionHERBST, R. S; PELLETIER, M; BOCZKO, E. M et al.Journal of virology. 1990, Vol 64, Num 1, pp 161-172, issn 0022-538XArticle

Positive and negative regulatory elements in the mouse albumin enhancerHERBST, R. S; FRIEDMAN, N; DARNELL, J. E. JR et al.Proceedings of the National Academy of Sciences of the United States of America. 1989, Vol 86, Num 5, pp 1553-1557, issn 0027-8424Article

Regulation of adenovirus and cellular gene expression and of cellular transformation by the E1B-encoded 175-amino-acid proteinHERBST, R. S; HERMO, H. JR; FISHER, P. B et al.Journal of virology. 1988, Vol 62, Num 12, pp 4634-4643, issn 0022-538XArticle

A Phase I study to assess the safety, tolerability, and pharmacokinetics of AZD4877, an intravenous Eg5 inhibitor in patients with advanced solid tumorsINFANTE, J. R; KURZROCK, R; HUSZAR, D et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 1, pp 165-172, issn 0344-5704, 8 p.Article

Phase I study of axitinib combined with paclitaxel, docetaxel or capecitabine in patients with advanced solid tumoursMARTIN, L. P; KOZLOFF, M. F; RADO, T et al.British journal of cancer. 2012, Vol 107, Num 8, pp 1268-1276, issn 0007-0920, 9 p.Article

Cross-sensitive rare-earth metal sensors based on bidentate neutral organophosphorus compounds and chlorinated cobalt dicarbollideLEGIN, A. V; KIRSANOV, D. O; BABAIN, V. A et al.Analytica chimica acta. 2006, Vol 572, Num 2, pp 243-247, issn 0003-2670, 5 p.Article

Surrogate markers in antiangiogenesis clinical trialsDAVIS, D. W; MCCONKEY, D. J; ABBRUZZESE, J. L et al.British journal of cancer. 2003, Vol 89, Num 1, pp 8-14, issn 0007-0920, 7 p.Article

Potential of the aminosterol, squalamine in combination therapy in the rat 13762 mammary carcinoma and the murine Lewis lung carcinomaTEICHER, B. A; WILLIAMS, J. I; TAKEUCHI, H et al.Anticancer research. 1998, Vol 18, Num 4A, pp 2567-2573, issn 0250-7005Article

Guillain-Barré syndrome following allogeneic bone marrow transplantationWEN, P. Y; ALYEA, E. P; SIMON, D et al.Neurology. 1997, Vol 49, Num 6, pp 1711-1714, issn 0028-3878Article

Chemotherapy for advanced non-small cell lung cancerHERBST, R. S; DANG, N. H; SKARIN, A. T et al.Hematology/oncology clinics of North America. 1997, Vol 11, Num 3, issn 0889-8588, vii,473-517 [46 p.]Article

The mouse albumin enhancer contains a negative regulatory element that interacts with a novel DNA-binding proteinHERBST, R. S; BOCZKO, E. M; DARNELL, J. E et al.Molecular and cellular biology (Print). 1990, Vol 10, Num 8, pp 3896-3905, issn 0270-7306Article